Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.
Duda A, Lee-Turner L, Fox J, Robinson N, Dustan S, Kaye S, Fryer H, Carrington M, McClure M, McLean AR, Fidler S, Weber J, Phillips RE, Frater AJ; SPARTAC Trial Investigators. Duda A, et al. Among authors: mclean ar. J Virol. 2009 Feb;83(3):1228-39. doi: 10.1128/JVI.01545-08. Epub 2008 Nov 19. J Virol. 2009. PMID: 19019964 Free PMC article.
Structured observations reveal slow HIV-1 CTL escape.
Roberts HE, Hurst J, Robinson N, Brown H, Flanagan P, Vass L, Fidler S, Weber J, Babiker A, Phillips RE, McLean AR, Frater J; SPARTAC trial investigators. Roberts HE, et al. Among authors: mclean ar. PLoS Genet. 2015 Feb 2;11(2):e1004914. doi: 10.1371/journal.pgen.1004914. eCollection 2015 Feb. PLoS Genet. 2015. PMID: 25642847 Free PMC article.
Modelling the evolution and spread of HIV immune escape mutants.
Fryer HR, Frater J, Duda A, Roberts MG; SPARTAC Trial Investigators; Phillips RE, McLean AR. Fryer HR, et al. Among authors: mclean ar. PLoS Pathog. 2010 Nov 18;6(11):e1001196. doi: 10.1371/journal.ppat.1001196. PLoS Pathog. 2010. PMID: 21124991 Free PMC article.
Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
Oxenius A, McLean AR, Fischer M, Price DA, Dawson SJ, Hafner R, Schneider C, Joller H, Hirschel B, Phillips RE, Weber R, Günthard HF; Swiss HIV Cohort Study Group. Oxenius A, et al. Among authors: mclean ar. J Virol. 2002 Oct;76(20):10169-76. doi: 10.1128/jvi.76.20.10169-10176.2002. J Virol. 2002. PMID: 12239291 Free PMC article.
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
Scherer A, Frater J, Oxenius A, Agudelo J, Price DA, Günthard HF, Barnardo M, Perrin L, Hirschel B, Phillips RE, McLean AR; Swiss HIV Cohort Study. Scherer A, et al. Among authors: mclean ar. Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12266-70. doi: 10.1073/pnas.0404091101. Epub 2004 Aug 9. Proc Natl Acad Sci U S A. 2004. PMID: 15302942 Free PMC article.
131 results